Hemay005 tablet

DRUG2 trials

Sponsors

Anhui Hemay Pharmaceutical Co., Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd

Conditions

Chronic Obstructive Pulmonary DiseaseUlcerative Colitis (UC)

Phase 1

Evaluation the Safety of hemay005 Tablets

CompletedNCT06908642

Anhui Hemay Pharmaceutical Co., LtdChronic Obstructive Pulmonary Disease

Start: 2024-12-25End: 2025-06-03Updated: 2025-12-09

Phase 3

Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis

Not yet recruitingNCT07650942

Ganzhou Hemay Pharmaceutical Co., LtdUlcerative Colitis (UC)

Start: 2026-06-01End: 2029-02-01Target: 360Updated: 2026-06-16